Evaluation of the self-administered indicator plaster neuropad for the diagnosis of neuropathy in diabetes

Diabetes Care

Volumn 31, Issue 2, 2008, Pages 236-237

  Tentolouris, Nicholas ^a,b   Achtsidis, Vasilis ^a   Marinou, Kyriaki ^a   Katsilambros, Nicholas ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIAGNOSTIC PROCEDURE; FEMALE; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DISABILITY EVALUATION; FEMALE; FOOT ULCER; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; SELF CARE; SENSITIVITY AND SPECIFICITY;

EID: 38949184240     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc07-1942     Document Type: Article

References (8)

1. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D, American Diabetes Association: Diabetic neuropathies: a statement by the American Diabetes Association (Position Statement). Diabetes Care 4:956-962, 2005
2. Hoeldtke RD, Bryner KD, Horvath GG, Phares RW, Broy LF, Hobbs GR: Redistribution of sudomotor responses is an early sign of sympathetic dysfunction in type 1 diabetes. Diabetes 502:436-443, 2001
3. Papanas N, Papatheodorou K, Christakidis D, Papazoglou D, Giassakis G, Piperidou H, Monastiriotis C, Maltezos E: Evaluation of a new indicator test for sudomotor function (Neuropad) in the diagnosis of peripheral neuropathy in type 2 diabetic patients. Exp Clin Endocrinol Diabetes 1134:195-198, 2005
4. Papanas N, Giassakis G, Papatheodorou K, Papazoglou D, Monastiriotis C, Christakidis D, Piperidou H, Maltezos E: Use of the new indicator test (Neuropad) for the assessment of the staged severity of neuropathy in type 2 diabetic patients. Exp Clin Endocrinol Diabetes 115:58-61, 2007
5. Papanas N, Giassakis G, Papatheodorou K, Papazoglou D, Monastiriotis C, Christakidis D, Piperidou H, Maltezos E: Sensitivity and specificity of a new indicator test (Neuropad) for the diagnosis of peripheral neuropathy in type 2 diabetes patients: a comparison with clinical examination and nerve conduction study. J Diabetes Complications 21:353-358, 2007
6. Papanas N, Papatheodorou K, Papazoglou D, Christakidis D, Monastiriotis C, Maltezos E: Reproducibility of the new indicator test for sudomotor function (Neuropad) in patients with type 2 diabetes mellitus: short communication. Exp Clin Endocrinol Diabetes 113:577-581, 2005
7. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH: A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 36:150-154, 1993
8. Liatis S, Marinou K, Tentolouris N, Pagoni S, Katsilambros N: Usefulness of a new indicator test for the diagnosis of peripheral and autonomic neuropathy in patients with diabetes mellitus. Diabet Med 24:1375-1380, 2007